SLC5A3 and cancer: Kyoto Encyclopedia of Genes and Genomes analyses revealed that genes co-expressed with SLC5A3 were enriched in multiple pathways involved in cancer progression, including Hippo, FOXO, JAK-STAT, and extracellular matrix pathways (Figure 1H).